Table 4 Linear regression analysis of cholesterol efflux/apoA-I ratio with glucose metabolism parameters.

From: HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial

 

Unadjusted model

Adjusted modela

β (SE)

P

β (SE)

P

Hb1Ac

−0.099 ± 0.140

0.479

−0.020 ± 0.017

0.250

Fasting glucose

0.299 ± 0.490

0.541

−0.160 ± 0.495

0.745

Fasting insulin

−0.480 ± 0.296

0.106

−0.577 ± 0.298

0.093

HOMA-IR

−0.110 ± 0.073

0.135

−0.193 ± 0.107

0.082

ISI

0.052 ± 0.125

0.677

0.128 ± 0.121

0.291

Disposition Index

0.056 ± 0.026

0.035

0.061 ± 0.027

0.023

  1. Data are presented as β ± SE: Unstandardised coefficients ± Standard Error.
  2. aAdjusted by age, sex, BMI, smoking status, alcohol drinking, lipid-lowering treatment, and batch number.
Back to article page